Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EGb 761 in Friedreich Ataxia
NCT00824512Phase 2Completed
- Sponsor
- Ipsen
- Start
- Jun 2008
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ginkgo biloba in Friedreich ataxia (FA), sponsored by Ipsen. Started Jun 2008; status: completed.
02
Drugs
ginkgo biloba
03
Conditions
Friedreich ataxia (FA)
Beyond the preview
Go deeper on NCT00824512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00824512.